Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D P M Hughes
Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Related publications
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
Gastroenterology
Hepatology
Gastroenterology
234. T Cells Genetically Modified to Express Chimeric Antigen Receptor Specific for EGFR for Glioma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
204. HER2-Specific Chimeric Antigen Receptor T Cells for the Treatment of Breast-To-Brain Metastasis
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells
Cancer Research
Cancer Research
Oncology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Application of Genetically Engineered Tumor-Specific Th1 Cells to Adoptive Tumor Immunotherapy
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
182. Genetically Engineered Malignant Glioma-Specific T Cells Resistant to Glucocorticoids
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
